Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 11;7:4.
doi: 10.1186/s13321-015-0053-y. eCollection 2015.

Data-driven Identification of Structural Alerts for Mitigating the Risk of Drug-Induced Human Liver Injuries

Affiliations
Free PMC article

Data-driven Identification of Structural Alerts for Mitigating the Risk of Drug-Induced Human Liver Injuries

Ruifeng Liu et al. J Cheminform. .
Free PMC article

Abstract

Background: The use of structural alerts to de-prioritize compounds with undesirable features as drug candidates has been gaining in popularity. Hundreds of molecular structural moieties have been proposed as structural alerts. An emerging issue is that strict application of these alerts will result in a significant reduction of the chemistry space for new drug discovery, as more than half of the oral drugs on the market match at least one of the alerts. To mitigate this issue, we propose to apply a rigorous statistical analysis to derive/validate structural alerts before use.

Method: To derive human liver toxicity structural alerts, we retrieved all small-molecule entries from LiverTox, a U.S. National Institutes of Health online resource for information on human liver injuries induced by prescription and over-the-counter drugs and dietary supplements. We classified the compounds into hepatotoxic, nonhepatotoxic, and possible hepatotoxic classes, and performed detailed statistical analyses to identify molecular structural fragments highly enriched in the hepatotoxic class beyond random distribution as structural alerts for human liver injuries.

Results: We identified 12 molecular fragments present in multiple marketed drugs that one can consider as common "drug-like" fragments, yet they are strongly associated with drug-induced human liver injuries. Thus, these fragments may be considered as robust hepatotoxicity structural alerts suitable for use in drug discovery screening programs.

Conclusions: The use of structural alerts has contributed to the identification of many compounds with potential toxicity issues in modern drug discovery. However, with a large number of structural alerts published to date without proper validation, application of these alerts may restrict the chemistry space and prevent discovery of valuable drugs. To mitigate this issue, we showed how to use statistical analyses to develop a small, robust, and broadly applicable set of structural alerts. Graphical abstractHepatotoxic-specific filters for flagging high risk compounds.

Keywords: Bioactivation; Drug-induced liver injury; Hepatotoxicity; Reactive metabolite; Structure alert.

Figures

Graphical abstract
Graphical abstract
Hepatotoxic-specific filters for flagging high risk compounds.
Figure 1
Figure 1
Molecular structural moieties defined by the SMARTS in Table 1 . Lowercase element symbols represent aromatic atoms of the element; the letter “a” matches any aromatic atom. Elements in square brackets match any of the elements in a molecule.

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

References

    1. Ahuja V, Sharma S. Drug safety testing paradigm, current progress and future challenges: an overview. J Appl Toxicol. 2014;34:576–94. doi: 10.1002/jat.2935. - DOI - PubMed
    1. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307–11. doi: 10.1001/jama.1997.03540280045032. - DOI - PubMed
    1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5. doi: 10.1001/jama.279.15.1200. - DOI - PubMed
    1. Kalgutkar AS. Role of bioactivation in idiosyncratic drug toxicity: structure-toxicity relationships. In: Elfarra AA, editor. Advances in bioactivation research. Vol. 8. New York: Springer; 2008. pp. 27–55.
    1. Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76:391–6. - PubMed

LinkOut - more resources

Feedback